Fingerprint
Dive into the research topics of 'A phase i multicenter study of continuous oral administration of lonafarnib (SCH 66336) and intravenous gemcitabine in patients with advanced cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically